Drawing for ARIL

USPTO serial 90191395

ARIL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CHISOLM, KEVON
Law office
TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ARIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Medical device, namely, carbon dioxide indicators; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting a synthetic aperature schlieren sensor, inductive field sensors, metal sponge chemical sensors, a deciated image processing and data processing engine, and wireless connectivity to applications resident on both computer and mobile hardware devices that are capable of being connected to the Internet and thereby transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices for treating congestive heart failure; Medical devices for treating sleep disorders; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical devices, namely, pulse oximeters; Medical apparatus, namely, an injectable oxygen delivery system comprising an oxygen device which produces nanobubbles and nanobatteries to prevent or treat eye disease; Medical apparatus, namely, bi-level positive airway pressure (BPAP) devices; Medical apparatus, namely, continuous positive airway pressure (CPAP) devices; Medical apparatus, namely, infusion and injection devices for administering drugs; Medical apparatus, namely, therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit; Medical apparatus, namely, variable positive airway pressure devices (VPAP); Blood pressure and diabetic diagnostic medical devices; Portable medical devices used for breathing exercises, namely, portable devices used for endogenous breathing exercises and for respiratory muscle training; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Telemetry devices for medical applicationsACTIVEMay 14, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 6, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 6, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2022CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 26, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 26, 2022EX1GSOU EXTENSION 1 GRANTED—
Jan 26, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 11, 2022IUAFUSE AMENDMENT FILED—
Jan 11, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 11, 2022NREVNOTICE OF REVIVAL - E-MAILED—
Jan 11, 2022TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jan 11, 2022PETGPETITION TO REVIVE-GRANTED—
Jan 11, 2022PROATEAS PETITION TO REVIVE RECEIVED—
Jan 10, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 10, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2021EXT1SOU EXTENSION 1 FILED—
Jun 8, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 13, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 13, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 24, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 5, 2021ALIEASSIGNED TO LIE—
Mar 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 2, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 16, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2021DOCKASSIGNED TO EXAMINER—
Oct 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance